These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10147049)

  • 1. Medicaid drug utilisation review under OBRA 1990: current issues and future directions.
    Fulda TR; Hass SL
    Pharmacoeconomics; 1992 Nov; 2(5):363-70. PubMed ID: 10147049
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacist's duty under OBRA-90 standards.
    Brushwood DB
    J Leg Med; 1997 Dec; 18(4):475-509. PubMed ID: 9433037
    [No Abstract]   [Full Text] [Related]  

  • 3. Pre-OBRA '90 Medicaid survey: how community pharmacy practice is changing.
    Pugh CB
    Am Pharm; 1995 Feb; NS35(2):17-23. PubMed ID: 7900647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations.
    Shorr RI; Fought RL; Ray WA
    JAMA; 1994 Feb; 271(5):358-62. PubMed ID: 8283585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final rule issued on Medicaid DUR and patient counseling.
    Am J Hosp Pharm; 1994 Dec; 51(24):3016, 3019. PubMed ID: 7856617
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug utilization review.
    Mergener MA
    J Am Assoc Med Transcr; 1996; 15(2):19. PubMed ID: 10156365
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicaid program; drug use review program and electronic claims management system for outpatient drug claims--HCFA. Final rule.
    Fed Regist; 1994 Sep; 59(184):48811-25. PubMed ID: 10137645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A primer on drug utilization review.
    Kubacka RT
    J Am Pharm Assoc (Wash); 1996 Apr; NS36(4):257-61, 279. PubMed ID: 8919601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing temperament and retuning of practice for pharmacists.
    Vogenberg FR
    Hosp Pharm; 1995 Oct; 30(10):902, 904-6. PubMed ID: 10151953
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.
    Mello MM; Studdert DM; Brennan TA
    N Engl J Med; 2004 Feb; 350(6):608-13. PubMed ID: 14762190
    [No Abstract]   [Full Text] [Related]  

  • 11. Hospitals the loser on Medicaid drug law--pharmacists.
    Wagner L
    Mod Healthc; 1991 Mar; 21(9):9. PubMed ID: 10109196
    [No Abstract]   [Full Text] [Related]  

  • 12. Changing physician prescribing practices. Regulation vs education.
    Kane RL; Garrard J
    JAMA; 1994 Feb; 271(5):393-4. PubMed ID: 8283590
    [No Abstract]   [Full Text] [Related]  

  • 13. An analysis of predictors of prescription drug costs among Medicaid nursing home residents in Texas.
    Johnsrud MT; Lawson KA
    Am J Manag Care; 1997 Sep; 3(9):1379-84. PubMed ID: 10178486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reimbursement factor in pharmaceutical regulation: rebates, cost-effectiveness, and practice guidelines.
    Shulman SR
    Pharmacoeconomics; 1992; 1(Suppl 1):21-7. PubMed ID: 10146927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Michigan drug utilization review and OBRA 90.
    Sandusky M
    Mich Med; 1993 Apr; 92(4):38-9. PubMed ID: 8231930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relational database for drug-use review of Tennessee Medicaid claims.
    Chyka PA; Holimon TD; Tepedino JT; Petersen H
    Am J Health Syst Pharm; 1996 Jan; 53(2):164-6. PubMed ID: 8653482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The financial impact of OBRA-90 on community pharmacies: an overview.
    Nightengale B; Reeder CE
    Clin Ther; 1993; 15(3):581-92. PubMed ID: 8364950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology.
    American Society of Clinical Oncology
    J Oncol Pract; 2014 Jul; 10(4):259-63. PubMed ID: 24737877
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescribing under OBRA. Myth and reality.
    Weiss KJ
    N J Med; 1991 Feb; 88(2):117-8. PubMed ID: 2002893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pharmacy mandates and practice standards now taking effect under OBRA '90 deadline.
    Fern FH
    Healthspan; 1993 Mar; 10(3):12-4. PubMed ID: 10125342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.